Ishihara Sangyo Kaisha (4028) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
6 Nov, 2026Executive summary
H1 FY2027 net sales fell 3.8% YoY to ¥73,571 million; operating profit dropped 58.2% to ¥3,080 million, and profit attributable to owners of parent was a loss of ¥999 million.
Comprehensive income was a loss of ¥135 million, versus income of ¥5,832 million in H1 FY2026.
Financial highlights
Net sales were ¥73,571 million, down 3.8% YoY; gross profit was ¥19,570 million versus ¥21,655 million, while SG&A rose to ¥16,490 million from ¥14,283 million.
Operating profit was ¥3,080 million, down 58.2% YoY; ordinary profit was ¥3,854 million, down 54.7%.
Profit attributable to owners of parent was a loss of ¥999 million, versus profit of ¥5,649 million; basic EPS was -¥26.09 versus ¥147.66.
Operating cash flow was ¥21,507 million, investing cash flow was -¥1,229 million, and financing cash flow was -¥9,502 million.
Outlook and guidance
FY2027 forecast: net sales ¥151,000 million (-2.5%), operating profit ¥15,800 million (-17.2%), ordinary profit ¥15,600 million (-28.2%), and parent-attributable profit ¥7,100 million (-57.3%).
Basic EPS forecast is ¥185.29; the financial results forecast was revised from the most recently announced forecast.
FY2027 annual dividend forecast is ¥130 per share, including a ¥50 second-quarter dividend; the dividend forecast was not revised.
Latest events from Ishihara Sangyo Kaisha
- Q1 FY2027 saw steep profit declines and a major impairment loss in Inorganic Chemicals.4028
Q1 2027 - Profits surged in FY2025, but FY2026/FY2027 is forecast to decline amid higher R&D and normalized demand.4028
Q4 2026 - Strong profit growth and positive outlook, driven by Organic Chemicals segment.4028
Q3 2026 - Net sales rose 10.4% but net income fell 80.6% due to forex losses and higher costs.4028
Q2 2025 - Q1 FY2025 profit dropped over 40% year-over-year despite stable sales; outlook revised down.4028
Q1 2025 - Sales and operating income rose, but net income fell; dividend forecast increased.4028
Q3 2025 - FY2025 is forecasted for higher profit and a ¥100 dividend as inorganic chemicals recover.4028
Q4 2025 - Operating profit surged 191% year-over-year, with strong sales and raised full-year guidance.4028
Q1 2026 - Profits and forecasts surged on strong overseas sales, cost controls, and a favorable outlook.4028
Q2 2026